Innovent Biologics Inc
HKEX:1801

Watchlist Manager
Innovent Biologics Inc Logo
Innovent Biologics Inc
HKEX:1801
Watchlist
Price: 85.2 HKD 1.85% Market Closed
Market Cap: 145.9B HKD

Wall Street
Price Targets

Price Targets Summary
Innovent Biologics Inc

Wall Street analysts forecast Innovent Biologics Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Innovent Biologics Inc is 107.28 HKD with a low forecast of 40.4 HKD and a high forecast of 144.27 HKD.

Lowest
Price Target
40.4 HKD
53% Downside
Average
Price Target
107.28 HKD
26% Upside
Highest
Price Target
144.27 HKD
69% Upside
Innovent Biologics Inc Competitors:
Price Targets
87S
Roivant Sciences Ltd
15% Upside
7774
Japan Tissue Engineering Co Ltd
154% Upside
ADMA
ADMA Biologics Inc
41% Upside
ARMP
Armata Pharmaceuticals Inc
56% Upside
HPHA
Heidelberg Pharma AG
63% Upside
BIOCON
Biocon Ltd
13% Upside
TNG
Transgene SA
71% Upside
688382
InventisBio Co Ltd
61% Upside

Revenue
Forecast

Revenue Estimate
Innovent Biologics Inc

For the last 7 years the compound annual growth rate for Innovent Biologics Inc's revenue is 144%. The projected CAGR for the next 4 years is 30%.

144%
Past Growth
30%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Innovent Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
Innovent Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Innovent Biologics Inc's stock price target?
Price Target
107.28 HKD

According to Wall Street analysts, the average 1-year price target for Innovent Biologics Inc is 107.28 HKD with a low forecast of 40.4 HKD and a high forecast of 144.27 HKD.

What is Innovent Biologics Inc's Revenue forecast?
Projected CAGR
30%

For the last 7 years the compound annual growth rate for Innovent Biologics Inc's revenue is 144%. The projected CAGR for the next 4 years is 30%.

Back to Top